Login to Your Account



Takeda and Biological E plan to jointly develop low-cost vaccines

By David Ho
Staff Writer

Friday, July 14, 2017

HONG KONG – Takeda Pharmaceutical Co. Ltd. and India’s Biological E Ltd. are collaborating to develop and deliver affordable combination vaccines.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription